Popular topics to explore
DEEPAKNTR
wholly owned arm, Deepak Chem Tech, has commissioned a hydrogenation plant at Dahej, Gujarat, with a total capex of ₹115 crore, aimed at boosting manufacturing capabilities and supporting future growth.
While this marks a strategic expansion, the company’s Q1FY26 results reflected pressure on performance, with net profit down 44.6% YoY to ₹112 crore from ₹202.5 crore, revenue lower by 12.8% at ₹1,889.8 crore, and EBITDA falling 38.8% to ₹189.3 crore, leading to a margin contraction to 10% from 14.3% last year. The new facility could help the company strengthen its position and gradually offset the current margin pressures.
Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.#WatchOutFor#StockInNews#FundamentalViews#EquityResearch#MacroViews
471 likes·65 comments

















